Chase Coleman III
Tiger Global Management
Chase Coleman III EXONE CO/THE stake
total: 436
Tiger Global Management XONE trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2013 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2014 Q2
According to 2026 Q2 report, Chase Coleman III doesn't hold any EXONE CO/THE (XONE) shares. To date, the estimated cost basis is nearly $60.46 for "buy" trades and estimated average "sell" price is $35.83. Tiger Global Management first purchased XONE in 2013 Q4, initially acquiring 665,000 shares. Since the initial investment in EXONE CO/THE (XONE), Tiger Global Management has made 1 more transaction.
When did Chase Coleman III sell EXONE CO/THE (XONE)?
Chase Coleman III sold off the entire EXONE CO/THE (XONE) position in 2014 Q2.
When did Chase Coleman III buy EXONE CO/THE (XONE)?
Chase Coleman III first invested in EXONE CO/THE (XONE) in 2013 Q4 at the reported quarter-end price of $60.46 per share.
What's the cost basis of Tiger Global Management's XONE stake?
The estimated cost basis for EXONE CO/THE (XONE) stake is around $60.46 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $60.46
- Weighted AVG sell price:
- $35.83
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.